24-Week Recurrence Rate of Gout Following Firsekibart Treatment | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
24-Week Recurrence Rate of Gout Following Firsekibart Treatment	Gout Flare	Not yet recruiting	Not applicable	2026-06-04		NCT07625514

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Second Affiliated Hospital, Zhejiang University, School of Medicine	561

11 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Changxin People's Hospital	Huzhou	China	2
Fuzhou University Affiliated Provincial Hospital	Fuzhou	China	3
Jinhua municipal central hospital	Jinhua	China	10
Ningbo Medical Center Lihuili Hospital	Ningbo	China	11
The First People's Hospital of Wenlin	Wenzhou	China	2
The Second Affiliated Hospital of Wenzhou Medical University	Wenzhou	China	13
The Second Affiliated Hospital of Zhejiang Chinese Medical University	Hangzhou	China	2
The Second Affiliated Hospital Zhejiang University School of Medicine	Hangzhou	China	18
Tongde Hospital of Zhejiang Province	Hangzhou	China	3
Zhejiang Hospital	Hangzhou	China	5
Zhejiang Provincial People's Hospital	Hangzhou	China	19